atezolizumab
Pronunciation: A-teh-zoh-LIZ-yoo-mab
Other Name(s): Tecentriq™
Apparence: clear colourless or slightly yellow liquid solution
mixed into larger bags of fluids
Les renseignements du Formulaire de médicaments s’adressent aux professionnels de la santé. Il ne s’agit pas d’un avis médical. Certains des renseignements, y compris ceux sur le financement des médicaments anticancéreux, ne s’appliquent pas à tous les patients. Les plans de traitement du cancer sont propres à chaque patient. Si vous êtes un patient, veuillez parler avec votre équipe soignante pour comprendre comment ces renseignements s’appliquent à vous.
Drug Monograph
mai 2025
Eligibility Forms
Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer Atezolizumab - Adjuvant Treatment for Non-Small Cell Lung Cancer Atezolizumab - Adjuvant Treatment for Non-Small Cell Lung Cancer Atezolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular CarcinomaPatient Info Sheet
mai 2025
What it is used for
- Atezolizumab is used to treat certain types of cancers such as lung, liver, or breast cancers.
- Atezolizumab is an immune therapy drug. For more information on immune therapy, see Immunotherapy Medications: What you need to know.
- For information about treatments that include both atezolizumab and chemotherapy, see our Treating cancer with chemotherapy and immunotherapy: What you need to know guide.